Lons Danic D, Lavarde V, Chahal M, Iseni MC, Marty O, Kazatchkine M; International Conference on AIDS.
Int Conf AIDS. 1991 Jun 16-21; 7: 255 (abstract no. W.B.2295).
Hospital Broussais, Paris, France
OBJECTIVE: To assess frequency, severity and difficulty to eradicate strongyloidiasis in HIV infected patients. METHODS: For 3 years 1988-1990, 462 parasites stools analysis from 201 HIV patients were performed for Strongyloides stercoralis (S.S.) by extraction Baiermann test in Broussais Hospital. RESULTS: Four patients had strongloidiasis (2 %), all of them travelled in tropical countries, none were treated with steroids. Patients 1 and 2 had diarrhea, no fever, no hypereosinophilia. Considering that patients presented recurrences, they needed 3 courses of thiabendazole. Patient 3 had severe diarrhea, mild fever and hypereosinophilia (8000/mm(3)), she was cured after 10 thiabendazole days treatment. Patient 4 had diarrhea, fever, no hypereosinophilia; she developed a severe extra intestinal infection, S.S. larvae were detected in sputum, bronchoalveolar lavage and stools samples. Three courses of thiabendazole and ivermectin associated treatment were necessary for recovery. CONCLUSION: Strongyloidiasis in HIV infected patients is an uncommon opportunistic parasitic disease, treatment remains difficult. Several and prolonged drugs courses seems to be necessary. Thiabendazole and ivermectin association may be interesting. Hyperinfection disease can be observed.
Publication Types:
Keywords:
- AIDS Vaccines
- Acquired Immunodeficiency Syndrome
- Animals
- Communicable Diseases
- Diarrhea
- Fever
- HIV Infections
- HIV Seropositivity
- Humans
- Ivermectin
- Parasitic Diseases
- Sjogren's Syndrome
- Strongyloides stercoralis
- Strongyloidiasis
- Thiabendazole
Other ID:
UI: 102192899
From Meeting Abstracts